Singular Genomics (OMIC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

OMIC Singular Genomics

Watchlist

21.900
-0.850-3.74%

Close Nov 15 16:00 ET

21.500
-0.400-1.83%

Post 20:01 ET

55.01MMarket Cap-631P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Singular Genomics Systems Inc: Qtrly Shr Loss $6.72
ReutersNov 12 16:23 ET
Earnings Flash (OMIC) SINGULAR GENOMICS SYSTEMS Reports Q3 Revenue $0.4M
MT NewswiresNov 12 16:22 ET
Singular Genomics | 10-Q: Q3 2024 Earnings Report
SECNov 12 16:18 ET · Announcements
Express News | Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
ReutersNov 12 16:05 ET
Press Release: Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
Dow JonesNov 12 16:05 ET
Nuwellis NUWE CMS Reimbursement; Singular Genomics OMIC Acquisition Offer
BioPharmCatalystNov 4 16:10 ET

Comments

LuckyLuke

Nov 4 06:52

$Singular Genomics (OMIC.US)$ net cash position $23.1/share

Stock_Drift

Nov 4 04:29

Pre Market Ticks. 11/4_5:28am

$Verona Pharma (VRNA.US)$ $Safe & Green Development (SGD.US)$ $Globalstar (GSAT.US)$ $SRM Entertainment (SRM.US)$ $Silo Pharma (SILO.US)$ $ESSA Pharma (EPIX.US)$ $SAG Holdings (SAG.US)$ $Tenaya Therapeutics (TNYA.US)$ $Air Transport Services (ATSG.US)$ $Hanryu Holdings (HRYU.US)$ $Vertex Pharmaceuticals (VRTX.US)$ $Singular Genomics (OMIC.US)$ $Nuwellis (NUWE.US)$ $Vast Renewables (VSTE.US)$
📊⚡️📊

Jaguar8

Nov 1 19:00

NEWS

$Singular Genomics (OMIC.US)$
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
SEC·

LuckyLuke

Oct 10 13:52

$Singular Genomics (OMIC.US)$ Hurry up

Jaguar8

Sep 19 16:25

Acquisition proposal of $12/sh 😂

$Singular Genomics (OMIC.US)$

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

OMIC Singular Genomics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target